文献
J-GLOBAL ID:202202237132125433
整理番号:22A0330027
ベンラリズマブ(PONENTE)で治療した重度,好酸球性喘息の成人における個別化還元アルゴリズムによる経口コルチコステロイド除去: 多施設,非盲検,単腕試験【JST・京大機械翻訳】
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
著者 (20件):
Menzies-Gow Andrew
(Royal Brompton and Harefield Hospitals, London, UK)
,
Gurnell Mark
(Wellcome-MRC Institute of Metabolic Science, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK)
,
Heaney Liam G
(Wellcome-Wolfson Centre for Experimental Medicine, Queen’s University Belfast, Belfast, UK)
,
Corren Jonathan
(David Geffen School of Medicine at UCLA, Los Angeles, CA, USA)
,
Corren Jonathan
(Allergy Medical Clinic, Los Angeles, CA, USA)
,
Bel Elisabeth H
(Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands)
,
Maspero Jorge
(Fundacion CIDEA, Buenos Aires, Argentina)
,
Harrison Timothy
(Respiratory Research Unit, Nottingham NIHR Biomedical Research Centre, University of Nottingham, UK)
,
Harrison Timothy
(BioPharmaceuticals R&D Digital, AstraZeneca, Cambridge, UK)
,
Jackson David J
(Guy’s Severe Asthma Centre, Guy’s and St Thomas’ NHS Trust, London, UK)
,
Jackson David J
(Asthma UK Centre, School of Immunology and Microbial Sciences, King’s College London, London, UK)
,
Price David
(Observational and Pragmatic Research Institute, Singapore)
,
Price David
(Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK)
,
Lugogo Njira
(University of Michigan Medical Center, Ann Arbor, MI, USA)
,
Kreindler James
(Global Medical Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE; USA)
,
Burden Annie
(Late Respiratory and Immunology and Biometrics, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK)
,
de Giorgio-Miller Alex
(Medical and Scientific Affairs, BioPharmaceuticals Medical, AstraZeneca, Luton, UK)
,
Padilla Kelly
(Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA)
,
Martin Ubaldo J
(Late Respiratory and Immunology, AstraZeneca, Gaithersburg, MD, USA)
,
Garcia Gil Esther
(Global Medical Respiratory, BioPharmaceuticals Medical, AstraZeneca, Barcelona, Spain)
資料名:
Lancet Respiratory Medicine
(Lancet Respiratory Medicine)
巻:
10
号:
1
ページ:
47-58
発行年:
2022年
JST資料番号:
W3111A
ISSN:
2213-2600
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)